NCT00368862View on ClinicalTrials.gov

Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2005

Study Completion Date

June 30, 2006

Conditions

AlcoholismDepression

Interventions

DRUG

Ebixa (memantine hydrochloride)

DRUG

Cipralex (escitalopram)

Trial Locations (1)

00251

National Public Health Institute, Department of Mental Health and Alcohol Research, Helsinki

All Listed Sponsors

collaborator

Finnish Foundation for Alcohol Studies

OTHER

lead

Finnish Institute for Health and Welfare

OTHER_GOV

NCT00368862 - Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism. | Biotech Hunter | Biotech Hunter